Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P F Searle

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Gene Therapy|May 18, 1999
Virus directed enzyme prodrug therapy for ovarian and pancreatic cancer using retrovirally delivered E. coli nitroreductase and CB1954I A McNeish, N K Green, M G Gilligan, et al.
Gene Therapy|May 28, 2004
Enhanced efficacy of Escherichia coli nitroreductase/CB1954 prodrug activation gene therapy using an E1B-55K-deleted oncolytic adenovirus vectorM-J Chen, N K Green, G M Reynolds, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 10, 2001
Combined adenovirus-mediated nitroreductase gene delivery and CB1954 treatment: a well-tolerated therapy for established solid tumorsA H Djeha, T A Thomson, H Leung, et al.
Gene Therapy|December 15, 2007
Escherichia coli nitroreductase plus CB1954 enhances the effect of radiotherapy in vitro and in vivoC L White, T Menghistu, K R Twigger, et al.
International Journal of Cancer|June 8, 2000
Sensitisation of human carcinoma cells to the prodrug CB1954 by adenovirus vector-mediated expression of E. coli nitroreductaseS J Weedon, N K Green, I A McNeish, et al.
Cancer Gene Therapy|July 1, 1997
Sensitization of colorectal and pancreatic cancer cell lines to the prodrug 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB1954) by retroviral transduction and expression of the E. coli nitroreductase geneN K Green, D J Youngs, J P Neoptolemos, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Gene Therapy|May 18, 1999
Virus directed enzyme prodrug therapy for ovarian and pancreatic cancer using retrovirally delivered E. coli nitroreductase and CB1954I A McNeish, N K Green, M G Gilligan, et al.
Gene Therapy|May 28, 2004
Enhanced efficacy of Escherichia coli nitroreductase/CB1954 prodrug activation gene therapy using an E1B-55K-deleted oncolytic adenovirus vectorM-J Chen, N K Green, G M Reynolds, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 10, 2001
Combined adenovirus-mediated nitroreductase gene delivery and CB1954 treatment: a well-tolerated therapy for established solid tumorsA H Djeha, T A Thomson, H Leung, et al.
Gene Therapy|December 15, 2007
Escherichia coli nitroreductase plus CB1954 enhances the effect of radiotherapy in vitro and in vivoC L White, T Menghistu, K R Twigger, et al.
International Journal of Cancer|June 8, 2000
Sensitisation of human carcinoma cells to the prodrug CB1954 by adenovirus vector-mediated expression of E. coli nitroreductaseS J Weedon, N K Green, I A McNeish, et al.
Cancer Gene Therapy|July 1, 1997
Sensitization of colorectal and pancreatic cancer cell lines to the prodrug 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB1954) by retroviral transduction and expression of the E. coli nitroreductase geneN K Green, D J Youngs, J P Neoptolemos, et al.
Pageof 4